Pliant Therapeutics, Inc. (PLRX) DCF Valuation

Pliant Therapeutics, Inc. (PLRX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Pliant Therapeutics, Inc. (PLRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of Pliant Therapeutics, Inc. (PLRX) with our user-friendly DCF Calculator! Enter your assumptions for growth, margins, and expenses to calculate the intrinsic value of Pliant Therapeutics, Inc. (PLRX) and enhance your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 57.1 41.8 7.6 9.7 1.6 .9 .5 .3 .2 .1
Revenue Growth, % 0 -26.7 -81.89 27.91 -83.69 -41.09 -41.09 -41.09 -41.09 -41.09
EBITDA -.1 -40.3 -95.7 -118.8 -158.2 -.7 -.4 -.3 -.2 -.1
EBITDA, % -0.20683 -96.46 -1264.24 -1227.15 -10014.43 -79.33 -79.33 -79.33 -79.33 -79.33
Depreciation 1.1 1.3 3.2 3.7 1.8 .3 .2 .1 .1 .0
Depreciation, % 1.95 3.13 42.31 38.01 116.52 37.08 37.08 37.08 37.08 37.08
EBIT -1.2 -41.6 -98.9 -122.5 -160.1 -.7 -.4 -.3 -.2 -.1
EBIT, % -2.16 -99.59 -1306.55 -1265.15 -10130.95 -80.35 -80.35 -80.35 -80.35 -80.35
Total Cash 102.8 276.9 200.6 331.2 494.2 .9 .5 .3 .2 .1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 7.4 9.4 2.0 2.0 3.0
Account Receivables, % 12.94 22.39 26.39 20.47 189.68
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 0.00001320655 0.000010325245 0 0.000004706359 0.000004706359 0.000004706359 0.000004706359 0.000004706359
Accounts Payable 1.3 2.0 3.0 1.6 4.5 .3 .2 .1 .1 .0
Accounts Payable, % 2.19 4.84 39.24 16.31 286.77 32.52 32.52 32.52 32.52 32.52
Capital Expenditure -1.0 -1.5 -2.0 -1.8 -.9 -.2 -.1 -.1 .0 .0
Capital Expenditure, % -1.69 -3.66 -25.79 -18.17 -58.29 -21.52 -21.52 -21.52 -21.52 -21.52
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT .4 -39.9 -89.9 -120.7 -160.1 -.6 -.3 -.2 -.1 -.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.6 -41.3 -80.3 -120.2 -157.2 -2.0 -.2 -.1 -.1 .0
WACC, % 9.45 9.6 9.59 9.6 9.6 9.57 9.57 9.57 9.57 9.57
PV UFCF
SUM PV UFCF -2.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -1
Present Terminal Value 0
Enterprise Value -3
Net Debt -52
Equity Value 49
Diluted Shares Outstanding, MM 59
Equity Value Per Share 0.84

What You Will Receive

  • Comprehensive Financial Model: Pliant Therapeutics’ actual data facilitates accurate DCF valuation.
  • Complete Forecasting Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate feedback as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation analysis.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Comprehensive PLRX Data: Pre-loaded with Pliant Therapeutics' historical financial performance and future growth forecasts.
  • Customizable Financial Inputs: Modify key metrics such as revenue growth, profit margins, WACC, tax rates, and capital expenditures.
  • Interactive Valuation Model: Automatically recalculates Net Present Value (NPV) and intrinsic value based on your customized inputs.
  • Scenario Analysis: Develop various forecast scenarios to evaluate different valuation possibilities.
  • User-Centric Interface: Intuitive design tailored for both industry professionals and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Pliant Therapeutics, Inc. (PLRX) data.
  • Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Pliant Therapeutics, Inc. (PLRX)'s intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports based on the outputs.

Why Choose This Calculator for Pliant Therapeutics, Inc. (PLRX)?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your financial analysis needs.
  • Real-Time Valuation: Observe immediate updates to Pliant Therapeutics’ valuation as you tweak the inputs.
  • Preloaded Data: Comes with Pliant Therapeutics’ actual financial information for swift evaluations.
  • Relied Upon by Experts: A go-to tool for investors and analysts aiming for informed decision-making.

Who Should Use This Product?

  • Pharmaceutical Students: Understand drug development processes and apply them using real-world case studies.
  • Researchers: Integrate advanced therapeutic models into academic projects or studies.
  • Investors: Evaluate your investment strategies and assess valuation outcomes for Pliant Therapeutics, Inc. (PLRX).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
  • Healthcare Entrepreneurs: Discover insights into how public biotech companies like Pliant Therapeutics are evaluated.

What the Template Contains

  • Pre-Filled Data: Includes Pliant Therapeutics' historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Pliant Therapeutics' profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

Es wurden keine passenden Produkte gefunden.